Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis

Journal of Clinical Investigation

Volumn 112, Issue 2, 2003, Pages 265-274

  Jambou, Florence ^a   Zhang, Wei ^b   Menestrier, Monique ^c   Klingel Schmitt, Isabelle ^a   Michel, Olivier ^d   Caillat Zucman, Sophie ^e   Aissaoui, Abderrahim ^a   Landemarre, Ludovic ^d   Berrih Aknin, Sonia ^a   Cohen Kaminsky, Sylvia ^a,c  

^a CNRS   (France)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^d AGRO BIO SAS   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; AUTOANTIBODY; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; GAMMA INTERFERON; HLA DR3 ANTIGEN; IMMUNOGLOBULIN G; RECEPTOR ANTIBODY; T CELL RECEPTOR ANTIBODY; T CELL RECEPTOR VACCINE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VACCINE; ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOREGULATION; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RECEPTOR BINDING; T LYMPHOCYTE; BLOOD; CELL DIVISION; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; ELECTROMYOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; KINETICS; SURFACE PLASMON RESONANCE; TIME;

ADOLESCENT; ADULT; ANTIBODIES; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ELECTROMYOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; KINETICS; MYASTHENIA GRAVIS; RECEPTORS, ANTIGEN, T-CELL; SURFACE PLASMON RESONANCE; T-LYMPHOCYTES; TIME FACTORS; VACCINES;

EID: 0041742401     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200316039     Document Type: Article

References (61)

1. Seddon, B., and Mason, D. 2000 The third function of the thymus. Immunol. Today. 21:95-99.
2. Sagakuchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 101:455-458
3. Vandenbark, A.A., Hashim, G.A., and Offner, H. 1996. T cell receptor peptides in treatment of autoimmune disease: rationale and potential. J. Neurosci. Res. 43:391-402.
4. Kumar, V., and Sercarz, E. 1999. Distinct levels of regulation in organ-specific autoimmune diseases. Life Sci. 65:1523-1530.
5. Zipp, F., et al. 1998. Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis. Brain. 121:1395-1407.
6. Cohen, J.R. 2001. T-cell vaccination for autoimmune disease: a panorama. Vaccine. 20:706-710.
7. Zang, Y.C., et al. 2000. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis. Eur. Immunol. 30:908-913.
8. Kumar, V., et al. 1997. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells. J. Immunol. 159:5150-5156.
9. Zhang, J., Medaer, R., Stinissen, P., Hafler, D., and Raus, J. 1993. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science. 261:1451-1454.
10. Hermans, G., Denzer, U., Lohse, A., Raus, J., and Stinissen, P. 1999. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination. J. Autoimmun. 13:233-246.
11. Sun, D., Qin, Y., Chluba, J., Epplen, J.T., and Wekerle, H. 1988. Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions. Nature. 332:843-845.
12. Kumar, V., and Sercarz, E. 1998. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells. J. Immunol. 161:6585-6591.
13. Elias, D., Tikochinski, Y., Frankel, G., and Cohen, I.R. 1999. Regulation of NOD mouse autoimmune diabetes by T cells that recognize a TCR CDR3 peptide. Int. Immunol. 11:957-966.
14. Haqqi, T.M., Qu, X.M., Anthony, D., Ma, J., and Sy, M.S. 1996. Immunization with T cell receptor Vβ chain peptides deletes pathogenic T cells and prevents the induction of collagen-induced arthritis in mice. J. Clin. Invest. 97:2849-2858.
15. Marchalonis, J.J., et al. 1992. Human autoantibodies reactive with synthetic autoantigens from T-cell receptor β chain. Proc. Natl. Acad. Sci. U. S. A. 89:3325-3329.
16. Hong, J., et al. 2000. Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination. J. Immunol. 165:6858-6864.
17. Bourdette, D.N., et al. 1994. Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic Vβ5.2 and Vβ6.1 CDR2 peptides. J. Immunol. 152:2510-2529.
18. Hashim, G.A., et al. 1992. Spontaneous development of protective anti-T cell receptor autoimmunity targeted against a natural EAE-regulatory idiotope located within the 39-59 region of the TCR-V beta 8.2 chain. J. Immunol. 149:2803-2809.
19. Hashim, G.A., et al. 1990. Antibodies specific for Vβ8 receptor peptide suppress experimental autoimmune encephalomyelitis. J. Immunol. 144:4621-4627.
20. Berrih-Aknin, S. 1995. Myasthenia gravis, a model of organ-specific autoimmune disease. J. Autoimmun. 8:139-143.
21. Drachman, D.B. 1994. Myasthenia gravis. N. Engl. J. Med. 330:1797-1810.
22. Willcox, N. 1993. Myasthenia gravis. Curr. Opin. Immunol. 5:910-917.
23. Drachman, D.B., Adams, R.N., Josifek, L.F., and Self, S.G. 1982. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N. Engl. J. Med. 307:769-775.
24. Hoch, W., et al. 2001. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7:365-368.
25. Vincent, A., Palace, J., and Hilton-Jones, D. 2001. Myasthenia gravis. Lancet. 357:2122-2128.
26. Newsom-Davis, J., et al. 1987. Immunological heterogeneity and cellular mechanisms in myasthenia gravis. Ann. N. Y. Acad. Sci. 505:12-26.
27. Engel, A.G. 1979. The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis. Prog. Brain Res. 49:423-434.
28. Lindstrom, J.M., Seybold, M.E., Lennon, V.A., Whittingham, S., and Duane, D.D. 1976. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 26:1054-1059.
29. Compston, D.A., Vincent, A., Newsom-Davis, J., and Batchelor, J.R. 1980. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 103:579-601.
30. Levine, G.D., and Rosai, J. 1978. Thymic hyperplasia and neoplasia: a review of current concepts. Hum. Pathol. 9:495-515.
31. Berrih-Aknin, S., et al. 1987. The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases. Ann. N. Y. Acad. Sci. 505:50-70.
32. Bofill, M., et al. 1985. Microenvironments in the normal thymus and the thymus in myasthenia gravis. Am. J. Pathol. 119:462-473.
33. Wakkach, A., et al. 1996. Expression of acetylcholine receptor gene in human thymic epithelial cells: implications for myasthenia gravis J. Immunol. 157:3752-3760.
34. Wheatley, L.M., et al. 1992. Molecular evidence for the expression of nicotinic acetylcholine receptor alpha-chain in mouse thymus J. Immunol. 148:3105-3109.
35. Salmon, A.M., Bruand, C., Cardona, A., Changeux, J.P., and Berrih-Aknin, S. 1998. An acetylcholine receptor α subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis. J. Clin. Invest. 101:2340-2350.
36. Cohen-Kaminsky, S., Levasseur, P., Binet, J.P., and Berrih-Aknin, S. 1989. Evidence of enhanced recombinant interleukin-2 sensitivity in thymic lymphocytes from patients with myasthenia gravis: possible role in autoimmune pathogenesis. J. Neuroimmunol. 24:75-85.
37. Leprince, C., et al. 1990. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis. J. Immunol. 145:2115-2122.
38. Moulian, N., et al. 1997. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody. Blood 89:3287-3295.
39. Berrih-Aknin, S., et al. 1991. T-cell antigenic sites involved in myasthenia gravis: correlations with antibody titre and disease severity. J. Autoimmun. 4:137-153.
40. Melms, A., et al. 1988. Thymus in myasthenia gravis. Isolation of T-lym phocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J. Clin. Invest. 81:902-908.
41. Sommer, N., Willcox, N., Harcourt, G.C., and Newsom-Davis, J. 1990. Myasthenic thymus and thymoma are selectively enriched in acetyl-choline receptor-reactive T cells. Ann. Neurol. 28:312-319.
42. Molnar, J., and Szobor, A. 1990. Myasthenia gravis: effect of thymectomy in 425 patients. A 15-year experience. Eur. J. Cardiothorac. Surg. 4:8-14.
43. Truffault, F., Cohen-Kaminsky, S., Khalil, J., Levasseur, P., and Berrih-Aknin, S. 1997. Altered intrathymic T-cell repertoire in human myasthenia gravis. Ann. Neurol. 41:731-741.
44. Aissaoui, A., et al. 1999. Prevention of autoimmune attack by targeting specific T cell receptor in a severe combined immunodeficiency mouse model of myasthenia gravis. Ann. Neurol. 46:559-567.
45. Vieira, M.L., et al. 1993. Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis. J. Neuroimmunol. 47:115-122.
46. Morel, E., et al. 1982. Assay of acetylcholine receptor antibodies in myasthenia gravis. A study of 329 sera [in French]. Nouv. Presse Med. 11:1849-1854.
47. Jaretzki, A., III, et al. 2000. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann. Thorac. Surg. 70:327-334.
48. Cathala, H.P. 1980. Electrological contribution to diagnosis of myasthenia gravis. Ann. Chir 34:159-160.
49. Kaveri, S., Kang, C.Y., and Kohler, H. 1990. Natural mouse and human antibodies bind to a peptide derived from a germline VH chain. Evidence for evolutionary conserved self-binding locus. J. Immunol. 145:4207-4213.
50. Hermanson, G.T. 1996. Glutaraldehyde-mediated hapten carrier conjugation. In Bioconjugate techniques. Academic Press. San Diego, California, USA. 453-454.
51. 86 HLA-DRβ dimorphism in autoantigen presentation to human T cells. Proc. Natl. Acad. Sci. U. S. A. 88:7343-7347.
52. Adorini, L., et al. 1990. New perspectives on immunointervention in autoimmune diseases. Immunol. Today. 11:383-386.
53. Dehghanpisheh, K., and Marchalonis, J.J. 1997. Retrovirally induced mouse anti-TCR monoclonals can synergize the in vitro proliferative T cell response to bacterial superantigens. Scand. J. Immunol. 45:645-654.
54. Marchalonis, J.J., et al. 1997. Analysis of autoantibodies to T-cell receptors among HIV-infected individuals: epitope analysis and time course. Clin. Immunol. Immunopathol. 82:174-189.
55. Liang, B., Marchalonis, J.J., Zhang, Z., and Watson, R.R. 1996. Effects of vaccination against different T cell receptors on maintenance of immune function during murine retrovirus infection. Cell. Immunol. 172:126-134.
56. Kaymaz, H., Dedeoglu, F., Schulter, S.F., Edmundson, A.B., and Marchalonis, J.J. 1993. Reactions of anti-immunoglobulin sera with synthetic T cell receptor peptides: implications for three-dimensional structure and function of the TCR beta chain. Int. Immunol. 5:491-502.
57. Kumar, V., and Sercarz, E.E. 1993. The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:909-916.
58. Ito, K., Tanaka, T., Tsutsumi, N., Obata, F., and Kashiwagi, N. 1999. Possible mechanisms of immunotherapy for maintaining pregnancy in recurrent spontaneous aborters: analysts of anti-idiotypic antibodies directed against autologous T-cell receptors. Hum. Reprod. 14:650-655.
59. Van Parijs, L., and Abbas, A.K. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science. 280:243-248.
60. Freiras, A.A., and Rocha, B. 2000. Population biology of lymphocytes: the flight for survival. Annu. Rev. Immunol. 18:83-111.
61. Vandenbark, A.A., et al. 2002. Regulation of autoimmunity with TCR peptides: latest breakthroughs. Sixth International Symposium on the Immunotherapy of the Rheumatic Diseases. http://www.kcl.ac.uk/ip/ jeremycridland/rsymp/abstracts-04.htm. (Abstr.)